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Background: An effective way to control cancer is by prevention. Ovarian cancer is the most lethal gynecological
malignancy. Progress in the treatment and prevention of ovarian cancer has been hampered due to the lack of an
appropriate animal model and absence of effective chemo-prevention strategies. The domestic hens spontaneously
develop ovarian adenocarcinomas that share similar histological appearance and symptoms such as ascites and
metastasis with humans. There is a link between chronic inflammation and cancer. Prostaglandin E2 (PGE2) is the
most pro-inflammatory ecoisanoid and one of the downstream products of two isoforms of cyclooxygenase (COX)
enzymes: COX-1 and COX-2. PGE2 exerts its effects on target cells by coupling to four subtypes of receptors which
have been classified as EP1-4. Fish oil is a source of omega-3 fatty acids (OM-3FAs) which may be effective in
prevention of ovarian cancer. Our objective was to assess the potential impact of fish oil on expression of COX
enzymes, PGE2 concentration, apoptosis and proliferation in ovaries of laying hens.
Methods: 48 white Leghorn hens were fed 50, 100, 175, 375 and 700 mg/kg fish oil for 21 days. The OM3-FAs and
omega-6 fatty acids contents of egg yolks were determined by Gas Chromatography. Proliferation, apoptosis,
COX-1, COX-2 and prostaglandin receptor subtype 4 (EP4) protein and mRNA expression and PGE2 concentration in
ovaries were measured by PCNA, TUNEL, Western blot, quantitative real-time qPCR and ELISA, respectively.
Results: Consumption of fish oil increased the incorporation of OM-3FAs into yolks and decreased both COX-1 and
COX-2 protein and mRNA expression. In correlation with COXs down-regulation, fish oil significantly reduced the
concentrations of PGE2 in ovaries. EP4 protein and mRNA expression in ovaries of hens was not affected by fish oil
treatment. A lower dose of fish oil increased the egg laying frequency. 175 and 700 mg/kg fish oil reduced
proliferation and 700 mg/kg increased apoptosis in hen ovaries.
Conclusions: Our findings suggest that the lower doses of fish oil reduce inflammatory PG and may be an
effective approach in preventing ovarian carcinogenesis. These findings may provide the basis for clinical trials
utilizing fish oil as a dietary intervention targeting prostaglandin biosynthesis for the prevention and treatment of
ovarian cancer.
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The best approach for reducing the impact of ovarian
cancer is by prevention. Fish oil supplementation as a
source of omega-3 fatty acids (OM-3FAs) might be ef-
fective in prevention and amelioration of the severity of
the ovarian cancer by targeting inflammatory prostaglan-
din pathways.* Correspondence: dhales@siumed.edu
Department of Physiology, Southern Illinois University Carbondale, School of
Medicine, Life Science II, Room 250 (M/C 6512), 1125 Lincoln Drive,
Carbondale, IL 62901, USA
© 2013 Eilati et al.; licensee BioMed Central Lt
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
waiver (http://creativecommons.org/publicdom
stated.Cyclooxygenase (COX) is the rate limiting enzyme in
catalyzing the conversion of arachidonic acid (AA) to
prostaglandins (PGs). Two isoforms of cyclooxygenase
have been identified, COX-1 and COX-2. Although both
COX isoforms have similar structure and function, they
are encoded by different genes (PTGS1 and PTGS2) and
show distinct expression patterns. COX-1 is expressed in
most cells and tissues and remains constant under most
physiologic conditions to play a housekeeping role
whereas the COX-2 form is inducible and usually only
expressed in response to various inflammatory stimulid. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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lishment [2] and maintenance of existing tumors [3].
Up-regulation of COX-2 has been reported in many ma-
lignancies including breast [4], lung [4] and ovarian can-
cer [5]. However, we and others have shown that COX-1
is over-expressed in ovarian cancer [3,6,7].
PGs are biologically active lipids that are associated
with inflammation, fever, pain and tissue injury [8]. High
concentrations of PGE2 are found in different human
cancers including colon, lung, breast, and head and neck
cancers [9]. Prostaglandins and their metabolites en-
hance the cell proliferation, inhibit apoptosis and stimu-
late cell adhesion. PGE2 exerts its autocrine/paracrine
effects on target cells by coupling to four subtypes of G-
protein coupled receptors, which have been classified as
EP1-4 [10]. EP4 is over-expressed in many cancers such
as castration-resistant prostate cancer [11] and colorec-
tal cancer [12] and EP4 antagonists inhibit breast cancer
metastasis in mice [13].
Ovarian cancer is the fifth leading cause of cancer
death among women and the most lethal gynecological
malignancy. Research into the discovery of early detec-
tion markers and therapeutics continues, but there are
still no effective treatments for ovarian cancer today
[14]. It is clear that poor diet is a well established risk
factor for cancer. In fact, the American Institute for
Cancer Research estimates that 30–40 percent of all can-
cers can be prevented by appropriate diets, physical ac-
tivity and maintenance of appropriate body weight [15].
Omega-6 fatty acids (OM-6FAs) and OM-3FAs are es-
sential poly unsaturated fats that must be obtained from
diet. OM-6FAs can be found in red meat, chicken and
vegetable seed oil such as sunflower seed oil. OM-3FAs
can be found in flaxseed and in oily cold water fish such
as salmon and tuna. The main OM-6FA, Linoleic Acid
(LA), is a direct precursor of the Arachidonic Acid (AA).
The OM-3FAs include alpha-linolenic acid (ALA), ei-
cosapentaenoic acid (EPA), and docosahexaenoic acid
(DHA). In early human diets, the ratio of OM-6FAs to
OM-3FAs was approximately equal; however, with the
evolution of the modern western diets, the ratio favored
the OM-6FAs that have been attributed to the increased
risk of cardiovascular disease and cancer [16]. In con-
trast, changing the ratio in favor of OM-3FAs has been
shown to have growth suppressive effects on cancerous
cells in animal studies [17]. Epidemiological evidence
and preclinical data suggest that consumption of OM-
3FAs might be associated with prevention of many can-
cers in humans likely due to reduction in inflammatory
prostaglandins. However, the mechanism(s) by which the
OM-3FAs in dietary fish oil, EPA and DHA, have anti-
neoplastic activity remains unclear [18].
Hens spontaneously develop ovarian adenocarcinomas
that are similar to human disease by histopathology [19],expression molecular markers [20-22] and presentation
of symptoms such as perfuse ascites fluid and peritoneal
metastatic dissemination [19,23].
Previously we have shown that increased expression of
both COX enzymes and concentration of PGE2 in hen
ovaries correspond to the increased incidence of ovarian
cancer indicating their importance in early stages of
ovarian cancer [24]. Moreover, we demonstrated that the
long-term consumption of flaxseed (richest plant source
of OM-3FAs) reduced the incidence and severity of
ovarian cancer in hens which correlated with reduced
COX-2 and PGE2 [25]. Thus, targeting COX expression
and prostaglandin biosynthesis by dietary intervention
using fish oil starting at young ages might be an effective
approach to prevent or suppress ovarian cancer later in
life. The objective of this study was to assess the effect
of fish oil on COX-1 and COX-2 enzyme expression and
PGE2 concentrations in normal ovaries of laying hens.Material and methods
Animal care
48 single comb white Leghorn hens, aged one year were
used. Hens were maintained two per cage and were pro-
vided with feed and water ad libitum and exposed to a
photoperiod of 17 h light: 7 h dark, with lights on at
05:00 h and lights off at 22:00 h. Animal management
and procedures were reviewed and approved by the In-
stitutional Animal Care and Use Committees at the Uni-
versity of Illinois at Urbana-Champaign and Southern
Illinois University at Carbondale.Experimental design
This study was performed in two parts. For the first part,
24 hens were randomly divided into four groups (n=6).
Three groups were fed 175, 375 and 700 mg/kg/day of
fish oil filled into the gelatin capsules and one group was
fed empty gelatin capsules. For the second part, 24 hens
were randomly divided into four groups (n=6) and three
groups were fed 50, 100 and 175 mg/kg/day of fish oil
and the empty gelatin capsules were given to the control
group. Eggs were collected daily to determine ovulation
rate which is reported as number of laid eggs per hen
per week. To ensure that the OM-3FAs from fish oil
were incorporated into the ovaries, four eggs from all
groups were collected on days 0, 7, 14 and 21 of the
study and measured for total OM-3FAs and OM-6FAs
contents by gas chromatography. If enough eggs were
not laid on a given day, the last laid eggs from previous
day were used. EPA and DHA contents of fish oil capsules
(500 mg omega-3 Salmon oil, Puritan’s Pride, Oakdale,
NY, USA) were measured and the manufactures reported
amounts confirmed. No overt toxicity was observed at
any dose.
Table 1 Primer sequences
COX-1
Forward 5′TCAGGTGGTTCTGGGACATCA 3′
Reverse 5′ TGTAGCCGTACTGGGAGTTGAA 3′
COX-2
Forward 5′ CTGCTCCCTCCCATGTCAGA 3′
Reverse 5′ CACGTGAAGAATTCCGGTGTT 3′
EP4
Forward 5′ GGTGTTTCATAGACTGGCGA 3′
Reverse 5′ GCAGATCACCGTAACCATGA 3′
SDHA
Forward 5′ CAGGGATGTAGTGTCTGCT 3′
Reverse 5′ GGGAATAGGCTCCTTAGTG 3′
TBP
Forward 5′ CGTCAGGGAAATAGGCA 3′
Reverse 5′ GACTGGCAGCAAGGAAG 3′
RPL4
Forward 5′ TTATGCCATCTGTTCTGC 3′
Reverse 5′ GCGATTCCTCATCTTACCCT 3′
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After 21 days, all hens were euthanized using CO2
asphyxation and necropsied. Ovaries were removed
from hens and small yellow follicles (6–8 mm) and pre-
ovulatory follicles (9–35 mm) were removed. The ovar-
ies were dissected into several pieces. The first portion
was frozen in liquid nitrogen and later stored at −80°C;
the second portion was put into RNAlater solution and
stored at 4°C before processing; the third and fourth
portions were used for histological analysis and fixed in
NBF fixative solution.
Gas chromatography
Measuring OM-3FA in egg yolks is a non-invasive ap-
proach in the poultry industry to measure total body OM-
3FA incorporation [26,27]. The yolk was separated from
the rest of the egg. A solution containing 12.5 ug/ml C17:0
standard in methanol was then added to the egg yolks.
Lipid extraction was performed using HPLC grade chloro-
form, water and HPLC grade hexane. The lipids were then
dried under a stream of nitrogen and methylated using
the Instant Metanolic HCl kit (Alltech, Lexington, KY,
USA). After methylation, the lipids were extracted twice
with hexane. Once dried under nitrogen, the lipids were
re-dissolved in hexane and injected into the Shimadzu
2010 gas chromatograph equipped with a flame ionization
detector. Helium was used as the carrier gas and nitrogen
as the make up gas with an Omega-wax column. The in-
jection volume was 1.0 μL, helium was used as the carrier
gas (30 cm/sec, 205°C), and Helium as the make-up gas
with an Omegawax (250, 30 m × 0.25 mm I.D., 0.25 μm
film) column. The injector temperature was 250°C. A split
injection technique (100:1) was used, and the temperature
program was as follows: 175°C held for 8 min, increased
to 200°C at 4.5°C/min, and held at 200°C for 8 min, then
increased to 230°C at 6°C/min, and held at 230°C for 14
min. Individual FAME were identified by reference to ex-
ternal standards (PUFA-3, and C17:0 Sigma-Adrich). Pro-
tein levels were determined by Pierce BCA Protein Assay.
Fatty acids were quantified by integration of area under
peak after normalization to C17:0 standards and to ug/ug
protein.
RNA extraction and analysis
Total RNA was extracted from ovarian tissue using Tri-
zol reagent. Quantification was performed by determin-
ation of absorbance at A260, and qualified by Experion
RNA StdSens Analysis. All RNA samples used in this
study had a 260:280 ratio range between 2 and 2.10, and
had three bands: 5S, 18S and 28S for electrophoresis re-
sults. RNA samples were then treated with RQ1 RNase-
free DNase prior to reverse transcription reaction. cDNA
was synthesized from DNase treated RNA with the high
capacity cDNA archive kit.Quantitative real-time PCR
The chicken-specific primers and plasmid standards
used for each gene were designed. Primer sequences are
shown in Table 1. qRT-PCR was conducted by amplify-
ing cDNA with Eva-Green on CFX384 Real-Time Sys-
tem and analyzed with Bio-Rad CFX Manager software.
Control reactions lacking template were run for each
gene. Reactions were 10 μl in total volume and 200 nM
of each primer. The amplification conditions were as fol-
lows: 50°C 5 S, 95°C 10 min, 40 cycles for 95°C 15 S,
60°C 1 min.
Western blot
The proteins were extracted from snap frozen ovarian
tissue samples and the western blot was performed to
detect COX-1 and COX-2 as described previously [24].
Apoptosis assay
The presence of apoptotic cells were detected with the
TUNEL Apoptosis Detection biotin-labeled POD Kit ac-
cording to manufacturer’s protocol (GenScript, Piscataway,
NJ, USA). Briefly, after deparaffinization of 5 μm PPFE
sections, they were washed with phosphate buffered saline
(PBS) and incubated with 0.02 mg/ml proteinase K at
37 C for 20 min. Cells were blocked with 3% hydrogen
peroxide in methanol for 10 min at RT. Sections were in-
cubated with a TUNEL labeling mixture of terminal deox-
ytransferase (TdT) and biotinylated dUTP at 37 C for 1
hr, followed by two washes in PBS for 5 min each. Apop-
totic cells were visualized with a streptavidin conjugated
antibody (Life Technologies, Carlsbad, CA, USA; Alexa
Fluor 488) at RT for 30 min. After being washed with PBS,
the sections were coverslipped using Fluormount G with
Dapi mounting media. For control staining, the positive
control section was treated for 15 min at 37 C with DNase
I (25 U/ul) before incubation with TUNEL labeling mix
while the negative control section was incubated in the
TUNEL labeling mix without TdT.
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Proliferating Cell Nuclear Antigen (PCNA) was used to
assess cell proliferation. Normal and cancerous ovaries
were fixed in 10% normal buffered formalin and paraffin
embedded blocks (PPFE) were sectioned at 5 μm. Sections
were deparaffinized in xylene and rehydrated in reducing
concentrations of ethanol. Antigen retrieval was per-
formed in a pressure cooker using unmasking solution
(Sigma) for 20 min, depressurized for 10 min, and then
allowed to cool to RT for 20 min changing ¼ of the water
every 5 min. The sections were treated with 3% hydrogen
peroxide in methanol for 30 min at room temperature
(RT) to block endogenouse peroxidase activity and rinsed
in Tris Buffered Saline with 0.5% tween (TTBS). Non spe-
cific binding was blocked using 2.5% normal horse serum
for 1 hr at RT then incubation with the mouse monoclo-
nal anti-PCNA antibody (Abcam, Cambridge, MA, USA)
for 16–18 hr at 4 C. Slides were washed with TTBS and
incubated with donkey anti mouse Alexa Fluor 488 sec-
ondary antibody (Jackson Immuno Research, West Grove,
PA, USA). for 1 hr at RT. Coverslips were applied using
Fluoromount G with Dapi mounting media (Southern
Biotech, Birmingham, Alabama, USA). Negative controls
were incubated without the primary antibody and showed
no staining.
TUNEL and PCNA analysis
Sections stained with either terminal deoxynucleotidyl
transferase dUTP nick end labeling (TUNEL) or the prolif-
erating cell nuclear antigen (PCNA) assay were analyzed
for positive stained cells in relation to the total number of
cells present. At least 3 animals from each treatment group
were serial sectioned. Sections from three areas of the ovary
were selected with at least 100 μm between sections. Pic-
tures of four different areas of each section were taken at
40×. Image J software was utilized to randomly mark 10 re-
gions of interest (ROI) in each area of each section. The
total number of cells was determined in these ROIs by nu-
clear Dapi staining. Percent of proliferation or apoptosis
was determined by the average positive stained cells divided
by the average total number of cells multiplied by 100.
PGE2 EIA
The amount of PGE2 in ovarian tissues from hens in all
groups was measured using a specific enzyme immuno-
assay as shown previously [24].
Statistical analysis
All experiments were performed in duplicate and differences
in data from groups were analyzed with GraphPad InStat
by using One-way ANOVA with Student–Newman–Keuls.
A value of P<0.05 was considered significant whereas a
value of P<0.01 was considered highly significant.Results
Amounts of OM-3FAs and OM-6FAs in egg yolks
The results indicated that there were significantly hi-
gher amounts of DHA in yolks collected from hens fed
100 mg/kg (P<0.05) and 175 mg/kg (P<0.01) fish oil com-
pared to amounts of DHA in yolks collected from control
hens (Figure 1A). EPA was not detectable in most groups
or it was extremely low. The yolks collected from hens fed
100 mg/kg fish oil had significantly lower amounts of AA
compared to yolks collected from control hens (Figure 1B;
P<0.05).Effect of fish oil on COX-1 mRNA and protein expression
in ovaries
Comparing the COX-1 protein expression in ovaries of
hens revealed that the groups of hens that were fed 100
and 175 mg/kg fish oil had significantly lower COX-1
protein expression compared to ovaries of control hens
(P<0.01; Figure 2A). Similar to the protein expression, a
significant reduction in expression of COX-1 mRNA was
observed in ovaries of the hens fed 100 and 175 mg/kg
fish oil compared to control hens (P<0.01; Figure 2B).Effect of fish oil on mRNA and protein COX-2 expression
in ovaries
A significant decrease in expression of COX-2 protein
and mRNA was seen in ovaries of hens fed 100 mg/kg fish
oil compared to control hens (P<0.05; Figure 2C & D).
The ovaries of hens fed 175 mg/kg fish oil had the lowest
COX-2 protein expression among groups which was sig-
nificantly lower than control hens (P<0.01). There was a
significant decrease in COX-2 mRNA expression in ovar-
ies of chickens fed 175 mg/kg fish oil in comparison to
control hens (P<0.05; Figure 2D).Fish oil consumption decreased PGE2 concentrations
in ovaries
In parallel with the results that we obtained for expres-
sion of COX enzymes, significantly lower concentrations
of PGE2 were detected in ovaries of hens fed 100 mg/kg
fish oil compared to ovaries of control hens (P<0.001;
Figure 3A). Furthermore, feeding the hens with 175 mg/
kg fish oil significantly reduced the PGE2 concentrations
in ovaries compared to ovaries of control hens (P<0.01).Effect of fish oil on EP4 mRNA and protein expression in
ovaries
There were no significant differences in expression of
EP4 among groups indicating that fish oil does not affect
the expression of EP4 protein and mRNA in ovaries of
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Figure 1 The amounts of OM-3FAs and OM-6FAs in egg yolks. Four egg yolks were collected from each group (n=4). (A) More DHA was
detected in yolks collected from hens treated with 100 mg/kg (P<0.05) and 175 mg/kg (P<0.01) fish oil compared to control hens. EPA was not
detectable in most of the treated groups or it was extremely low. (B) The yolks collected from hens treated with 100 mg/kg fish oil had
significantly lower amounts of AA compared to yolks collected from control hens (P<0.05). *, P<0.05; **, P<0.01. Bars indicate standard error.
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At the end of first week of the study, the ovulation rate
(egg laying frequency) of all fish oil-fed hens was compared
to control group, no significant differences were seen. Fish
oil did not have any effect on ovulation rate of hens com-
pared to control hens in second week (P>0.05; Figure 3C).
After being on fish oil for 3 weeks, the egg laying frequency
of hens that were fed 100 mg/kg fish oil was significantly
increased compared to the ovulation rate of the same
group on first week and ovulation rate of control group on
third week (P<0.05). The ovulation rate in 700 mg/kg fish
oil-fed hens was significantly decreased in weeks two and
three compared to week one (P<0.05).
Effect of fish oil on apoptosis and proliferation
As shown in Figure 4, 700 mg/kg fish oil increased the rate
of apoptosis in ovaries, whereas the other doses failed to
show such an effect (P<0.001). The assessment of cellproliferation by PCNA staining is an indicator of prolifera-
tive growth. We observed that the population of PCNA-
positive cells in ovary sections was substantially lower than
controls when the hen’s diet were supplemented with 175
and 700 mg/kg fish oil (P<0.05; Figure 5).
Discussion
Here, we report that the consumption of fish oil signifi-
cantly increases the DHA incorporation into egg yolks,
decreases the AA contents of yolks, and reduces both
COX-1 and COX-2 protein and mRNA expression in
hen ovaries. Moreover, in correlation with down-
regulation of COX enzymes, fish oil significantly reduces
the concentrations of PGE2 in ovaries. EP4 protein and
mRNA expression in ovaries of hens was not affected by
fish oil treatment. A lower dose of fish oil increased the
egg laying frequency. 175 and 700 mg/kg fish oil reduced
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Figure 2 COX-1 and COX-2 expression in ovaries of control and fish oil-fed hens. (A & B) The hens treated with 100 mg/kg (n=6) and 175
mg/kg (n=8) fish oil had significantly lower COX-1 protein and mRNA expression compared to ovaries of control hens (n=8; P<0.01). (C & D) A
significant reduction in expression of COX-2 protein and mRNA was seen in ovaries of hens treated with 100 mg/kg fish oil (n=6) compared to
control hens (n=8; P<0.05). The ovaries of hens fed 175 mg/kg fish oil (n=8) had the lowest COX-2 protein expression among groups which was
significantly lower than control hens (n=8; P<0.01). There was a significant decrease in COX-2 mRNA expression in ovaries of chickens treated
with 175 mg/kg (n=8) fish oil in comparison to control hens (n=8; P<0.05). *, P<0.05; **, P<0.01. Bars indicate standard error.
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sion and PGE2 concentration was in “U-shaped curve”
manner meaning that the increasing doses of fish oil cor-
relate with reduction of COX and PGE2 until an optimal
dose is reached beyond which further dose increases re-
sult in less effect. This finding was correlated to an
“inverted U-shaped curve” of DHA amounts found in egg
yolks. The concept of “U-shaped curve” refers to a nonlin-
ear relationship between two variables, in this case fish oil
dose and prostaglandin production (or COX expression).
The nonlinear response, typical of many biological systems,
indicates that in the optimum dose-range (100–175 mg/kg)
prostaglandin production was maximally inhibited. At
higher doses of fish oil the hens react in an adverse
way and do not tolerate the treatment.
Incorporation of OM-3FAs into egg yolks of fish oil-
fed hens provides a non-invasive measure of the incorp-
oration of OM-3FAs into ovaries of the hens. EPA is
normally found in much lesser abundance than DHA intissues and no specific physiological response is directly
attributable to EPA [4,28]. Equal amounts of DHA and
EPA were detected in fish oil (data not shown) but our
data showed that EPA was not detectable or was ex-
tremely low in egg yolks collected from all groups. It is
likely due to its conversion to DHA by Δ6-desaturase.
DHA is the most prominent OM-3FA in the egg yolk
[29] and we detected higher amounts of it compared to
ALA and EPA in yolks. DHA contents of egg yolks col-
lected from hens fed 100 and 175 mg/kg fish oil were
significantly higher compared to controls. We did not
detect higher amounts of DHA in egg yolks of hens fed
higher doses of fish oil. Broughton et al. has reported that
low EPA/DHA ingestion resulted in nearly as much total
OM-3FA incorporation into ovarian tissue as high EPA/
DHA ingestion, indicating that ovarian tissue OM-3FA in-
corporation may be saturable [30]. This may explain why
when the fish oil was fed in higher than a certain dose,
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Figure 3 PGE2 concentration in ovaries. (A) The hens treated with 100 mg/kg (n=6; P<0.001) and 175 mg/kg fish oil (n=8; P<0.01) had lower
concentrations of PGE2 in the ovaries compared to ovaries of control hens (n=8). (B & D) There were no significant differences in expression of
EP4 among groups (P>0.05). (C) After 3 weeks of fish oil supplementation, the egg laying frequency of hens that were treated with 100 mg/kg
fish oil was significantly increased compared to the ovulation rate of the same group on first week and ovulation rate of control group on third
week (P<0.05). The ovulation rate in 700 mg/kg fish oil-treated hens was significantly decreased in weeks two and three compared to week one
(P<0.05). *, P<0.05; **, P<0.01; ***, P<0.001. Bars indicate standard error.
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mg/kg were lower than DHA content of yolks collected
from lower doses. Feeding the hens with 700 mg/kg fish
oil for one week resulted in malabsorption of lipids and a
diarrhetic response which may explain the lower DHA
content of yolks. In general, our data indicated that fish
oil increases the incorporation of OM3-FAs into the eggs
which was in agreement with previous studies [31,32].
The amounts of AA in yolks collected from 100 mg/kg
fish oil-fed hens were lower than the amounts of AA in
yolks collected from the control group. It might be due
to replacement of AA by DHA in membranes of ovarian
cells as suggested by Schreiner et al. who reported that
after treating hens with OM-3FAs, there was an almost
complete exchange of AA and DHA in the sn-2 position
of phosphatidylcholine and phosphatidylethanolamine in
the egg yolk [29]. Meluzzi et al. reported that the feed-
ing with fish oil caused a dramatic increase in all OM-
3FAs of the yolk and caused an appreciable decrease in
AA [32]. They proposed that this phenomenon is prob-
ably due to the greater utilization of Δ6-desaturase in
the OM-3FA pathway with respect to the OM-6FApathway, as this enzyme acts in both pathways [32].
Moreover, they noted that a lower dose of fish oil de-
creased AA in yolks more than a higher dose. High con-
centrations of dietary OM-3FAs reduce the activity of
the enzyme in the OM-6FAs pathway and the conver-
sion of linoleic acid into AA which could be important
for human health, as this acid is a precursor of pro-
inflammatory eicosanoids namely PGE2 [33].
The molecular basis for the health benefits of dietary
fish oil is likely due to incorporation of EPA and DHA
into the membrane [4]. The fatty acid composition of
phospholipids is a key determinant of the ability of COX
enzymes to function, and this can be influenced by diet
[34]. We measured the expression of COX enzymes in
ovaries to see if it is influenced by dietary fish oil. The ex-
pression of COX-1 protein and mRNA was significantly
decreased in ovaries of 100 and 175 mg/kg fish oil-fed
hens. The COX and PGE2 endpoints are tightly correlated
with the incorporation of DHA into the yolks. This was in
agreement with the studies that showed the DHA [35]
and EPA [4] found in fish oil are effective inhibitors of
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Figure 4 TUNEL staining of the ovaries. Supplementation with 700 mg/kg fish oil increased the number of apoptosis in the hen ovaries
(P<0.001). Bars indicate standard error.
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PGE2 synthesis by COX-1 in ovarian cancer cell lines [36]
has been previously shown. Targeting COX-1 in ovarian
cancer is one of the beneficial actions of fish oil which
may attenuate and even suppress this disease.
Several studies have shown that OM-3FA enriched di-
ets inhibit COX-2 and prostaglandins in both plasma
and experimentally induced tumors [37] but the effect of
fish oil on COX-2 expression in ovaries of hens was un-
known. Our data indicated that COX-2 expression at the
transcriptional level was decreased in ovaries of hens fed
100 and 175 mg/kg of fish oil resulting in decreased
COX-2 protein. This was in agreement with a study that
reported a significant decrease in COX-2 expression
both in the colonic mucosa and in colon tumors of rats
fed fish oil [38]. Aronson et al. showed that fish oil de-
creases the COX-2 expression in prostatic tissue of men
[39]. The mechanism through which fish oil reduces theexpression of COX-2 remains to be completely eluci-
dated but the inhibitory effect of DHA on COX-2 pro-
motor activity, mRNA levels and protein expression in
human endothelial cells has been reported [40]. NF-κB
is a transcription factor that plays an important role in
various inflammatory signaling pathways and controls
effectors enzymes such as COX-2 [41]. Previous studies
have shown that fish oil supplementation inhibited NF-κB
activation [42,43] which in turn leads to down-regulation
of COX-2.
Previous findings have demonstrated that fish oil sup-
plementation in human diets decreases production of
PGE2 [44-47], but the effect of fish oil on PGE2 concen-
tration in hen ovaries had not been investigated. Our re-
sults indicated that there was a statistically significant
reduction in concentration of PGE2 in ovaries of hens
fed 100 and 175 mg/kg fish oil compared to controls.








Control 50 100 175 375 700




Figure 5 PCNA staining of the ovaries. The number of proliferative cells in ovary sections in hens fed 175 and 700 mg/kg fish oil was
substantially lower than controls (P<0.05). Bars indicate standard error.
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modulate substrate pools available to COXs and lipoxy-
genases (LOX), thereby controlling the downstream ei-
cosanoid formation and subsequent receptor activation
[48]. COX enzymes convert OM-6FAs to 2-series PG
products such as PGE2 whereas the end products of COX
enzymes activity on OM-3FAs are 3-series prostaglandins
such as PGE3. The 3-series PG products are generally less
pro-inflammatory than the 2-series products [49-51].
Prostaglandins are potent mediators of intercellular com-
munication, and high concentrations of PGE2 are believed
to be immunosuppressive of T cell-mediated immunity
[52], increase angiogenesis [53], stimulate cell prolifera-
tion and inhibit apoptosis in ovarian cancer cell lines [54].
Elevation of PGE2 in ovarian cancer has been previously
reported [55]. We have shown that at the age when ovar-
ian cancer was detected for the first time in hens, PGE2
concentration and COX expression were elevated inovaries [24] pointing to the important role of COX en-
zymes and PGE2 in the early stages of ovarian carcinogen-
esis. Recently, we reported that consumption of flaxseed
enriched diet, the richest plant source of OM-3FAs, re-
duced the ovarian cancer severity and incidence in hens
which was correlated to decreased concentration of PGE2
and expression of COX-2 in ovaries [25,56].
EP4 receptor promotes tumor progression by increasing
pro-angiogenic factor and tumor cell invasiveness in ovar-
ian carcinoma cell lines. Spinella et al. reported that EP2-
EP4 signaling regulates vascular endothelial growth factor
production and ovarian carcinoma cell invasion [57]. Our
study demonstrated that consumption fish oil does not
affect expression of EP4 at the level of mRNA or protein.
COX-2 governs innumerable physiological processes in-
cluding ovulation. PGE2 action on granulosa cells is essen-
tial for successful ovulation [58]. There was a concern
that reduced expression of COX-2 and concentration of
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higher number of ovulations in hens fed 100 mg/kg fish
oil at the end of third week compared to first week of the
study. This finding was in agreement with Broughton
et al. who has shown that consumption of fish oil
resulted in an elevated ovulation rate in rats [30].
Incorporation of OM3-FA appears to enhance ovulation
by reducing excess inflammatory PGE2 possibly through
reduced AA availability and decreased COX-2 [30].
One of the hallmarks of cancer is the net gain of cancer-
ous cells, either through excessive proliferation or through
failure of programmed cell death (apoptosis). We postu-
lated that fish oil reduces the proliferation and increases
the apoptosis of hen ovarian cells. Our data indicated an
increase in the rate of apoptosis in ovaries of the hens fed
the highest fish oil dose. Proliferation was lower in the
group of hens fed lower doses of fish oil. Our findings
were in agreement with previous studies which have
shown that fish oil increases apoptosis [59] and decreases
proliferation in rat mammary tumors [60]; fish oil pre-
vents colon carcinogenesis by enhancing apoptosis in the
colon [61,62]. Thus measurement of apoptosis vs prolifer-
ation provides an index of therapeutic efficacy. By target-
ing apoptosis and proliferation, fish oil at the optimum
concentration reduces the pro-carcinogenic environment
potentially resulting in prevention of cancer initiation.
In conclusion, our findings show that dietary inter-
vention with fish oil decreases the expression of COX-1,
COX-2 and the concentration of PGE2 which likely re-
duces the carcinogenic microenvironment in ovaries of the
laying hens. Fish oil has been reported to be immune-
suppressive at high concentrations and immune-stimulatory
at lower concentration in chickens [31,63,64]. The reduc-
tion in PGE2 appears to be primarily due to inhibition of
both COX enzymes, and it is likely that substrate modula-
tion of both COX enzymes further contributes to the
reduction in PGE2 levels. It is generally agreed that an
effective way to control cancer is to find better ways of
preventing it. Chemopreventive approaches are recom-
mended for women who have a family history of cancer
or express other known risk factors for ovarian cancer
[65]. To our knowledge the present study provides the
first insight into the efficacy of fish oil on the reduction of
COX enzyme expression and PGE2 concentration in the
normal pre-cancerous ovary and further demonstrates the
utility of the hen model for ovarian cancer. Our study
provides new insight into the potential mechanism of ac-
tion of fish oil in the reduction of ovarian cancer and will
establish the foundation for clinical trials to test the effi-
cacy of dietary intervention with fish oil for the prevention
and suppression of ovarian cancer in women.Competing interests
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